FDA authorizes new guidance on Pfizer vaccines and boosters for children and adults
On Jan. 3, 2022, the Food and Drug Administration (FDA) amended the authorization of emergency use of the Pfizer-BioNTech COVID-19 vaccine guidance in three ways.
Tag: Western States Scientific Safety Review Workgroup
Western States Scientific Safety Review Group recommends pediatric doses of Pfizer vaccine for children ages 5 to 11
Following review of recommendations by the Advisory Committee on Immunization Practices (ACIP) and the Centers for Disease Control and Prevention (CDC), the Western States Scientific Safety Review Workgroup has confirmed that pediatric doses of the Pfizer COVID-19 vaccine for children are safe and effective for children ages 5 through 11.
Booster doses for specific groups recommended by Western States Scientific Safety Review Workgroup
The Western States Scientific Safety Review Workgroup has made the following recommendations about COVID-19 booster doses for fully vaccinated people.
Medical and public health experts determine when to recommend a booster
Medical and public health experts determine when to recommend a booster. This week, the U.S. Food and Drug Administration (FDA) will consider whether to recommend that individuals who were vaccinated with Johnson & Johnson and Moderna COVID-19 vaccines should get booster doses.
How federal decisions on COVID-19 vaccines make their way to Oregon consumers
On Oct. 7, 2021, Pfizer and BioNTech asked the Food and Drug Administration (FDA) to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11. So when can children under age 12 in Oregon be vaccinated? The answer depends on how long it takes for the decision to make its way through the process to authorize vaccinations in Oregon.
Pfizer-BioNTech booster for specific groups recommended by Western States Scientific Safety Review Workgroup
The Western States Scientific Safety Review Workgroup has recommended the following groups of people who received the Pfizer vaccine should receive a booster dose of the Pfizer vaccine at least six months after their second dose: People 65 and older, People living in a long-term care facility, and People 50-64 with underlying medical conditions. People […]
OHA releases statement on booster dose recommendation
Today, officials from the Food and Drug Administration (FDA) convened medical experts to discuss whether to recommend that people who’ve previously been fully vaccinated with the Pfizer COVID-19 vaccine should receive a booster shot to help maintain the effectiveness of their vaccinations over time. At today’s hearing, the committee recommended that people age 65 and […]
FDA, CDC and Western States recommend additional vaccine dose for immunocompromised individuals
The U.S. Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC) and Western States Scientific Safety Review Workgroup have all recommended an additional dose of mRNA COVID-19 vaccine be administered to people with moderately to severely compromised immune systems. On Aug. 12, the U.S. Food and Drug Administration (FDA) adjusted the existing […]
Western states workgroup approves vaccinations for individuals 12 and older
On May 12, The Western States Scientific Safety Review Workgroup convened to review the federal government’s Emergency Use Authorization (EUA) that extended COVID-19 vaccine eligibility to individuals ages 12 and older. In their official statement, the workgroup concluded that the Pfizer-BioNTech COVID-19 vaccine is “safe and effective in this age group and supports its use.” […]
Oregon to resume Johnson & Johnson vaccinations
On April 24, the Oregon Health Authority announced that Oregon health care providers and pharmacies could resume administering the Johnson & Johnson COVID-19 vaccine throughout Oregon. This announcement came a day after the U.S. Food and Drug Administration (FDA) lifted the pause that had been placed on the Johnson & Johnson COVID-19 vaccine since April 13. The FDA and the Centers […]